Associate Professor, Medicine, Case Western Reserve University School of Medicine
Infectious Disease
Dr. Carlos S. Subauste, MD
|
|
Give Review
Dr. Carlos S. Subauste practices Infectious Disease. Doctor Carlos S. Subauste, MD is a published doctor. He published 50 publications, including: 'Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
- Atg5 but not Atg7 in dendritic cells enhances IL-2 and IFN-γ production by Toxoplasma gondii-reactive CD4(+) T cells.
- PRO-INFLAMMATORY RESPONSES INDUCED BY CD40 IN RETINAL ENDOTHELIAL AND MULLER CELLS ARE INHIBITED BY BLOCKING CD40-TRAF2,3 OR CD40-TRAF6 SIGNALING.
- CD40 promotes the development of early diabetic retinopathy in mice.
- Toxoplasma gondii-Induced Activation of EGFR Prevents Autophagy Protein-Mediated Killing of the Parasite.
- Modulation of Retinal Muller Cells by Complement Receptor C5aR.
- The Protein Kinase Double-Stranded RNA-Dependent (PKR) Enhances Protection against Disease Cause by a Non-Viral Pathogen.
- CD40 induces anti-Toxoplasma gondii activity in non-hematopoietic cells dependent on autophagy proteins.
- Animal models for Toxoplasma gondii infection.
- Studies on the role of interleukin-12 in acute murine toxoplasmosis.
- Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection.
- Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in ...
- CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response t...
- Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals.
- Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
- Cells and cytokines in resistance to Toxoplasma gondii.
- Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.
- Toxoplasma-macrophage interactions.
- Immunity to Toxoplasma gondii.
- Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis fact...
- Primary immunodeficiencies and susceptibility to parasitic infections.
- The role of cytokines in toxoplasmosis.
- Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotox...
- Tocainide-induced pulmonary toxicity.
- Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.
- Role of gamma interferon in Toxoplasma gondii infection.
- Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
- CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.
- Review of the series "Disease of the year 2011: toxoplasmosis" pathophysiology of toxoplasmosis.
- Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success.
- The CD40-autophagy pathway is needed for host protection despite IFN-?-dependent immunity and CD40 induces autophagy via control of P21 levels.
- Photoreceptor cells constitutively express functional TLR4.
- HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.
- Autophagy in immunity against Toxoplasma gondii.
- Autophagy as an antimicrobial strategy.
- Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry.
- CD40 and the immune response to parasitic infections.
- CD40, autophagy and Toxoplasma gondii.
- CD40 mediates retinal inflammation and neurovascular degeneration.
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
- Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4(+) T cells from HIV-1-infected patients.
- CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages.
- CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.
- CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.
- TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha.
- CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
- Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients.
- CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism.
- CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection.
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Great West Healthcare-Cigna PPO
- Cofinity PPO
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Southern Illinois University -
Cayetano Heredia University
Hospital
-
University Hospitals Case Medical Center
Drug Facts
| NPI NUMBER | 1861421505 | |
| NPPES Provider LastName | SUBAUSTE | |
| NPPES Provider FirstName | CARLOS | |
| NPPES Provider ZIPCode | 441061716 | |
| NPPES Provider State | OH | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 504.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861421505 |
| Last Name Of The Provider | SUBAUSTE |
| First Name Of The Provider | CARLOS |
| View All |
Similar Doctors
|
|
Dr. Marisa T. Tungsiripat, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sorabh Dhar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicola Helm, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Willem H. Boom, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Curtis J. Donskey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Charles H. King, MD |
|
|
Dr. Carlos M. Isada, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amy J. Ray, MD |